AI, Inc. 4388

NEW YORK, September 02, 2026--Paradium.AI, Inc. (NYSE American: PAAI), an AI-driven technology platform operating at the intersection of IP, data and commerce engineered to empower creators, media entrepreneurs, publishers and brands, today announced a strategic partnership with Elcano, a curation enablement company that empowers publishers, data providers and agencies to build, operate and scale supply-side curation capabilities.

NEW YORK, September 01, 2026--Paradium.AI, Inc. (NYSE American: PAAI), an AI-driven technology platform operating at the intersection of IP, data and commerce engineered to empower creators, media entrepreneurs, publishers and brands, today announced its participation in the Lake Street Capital Markets Best Ideas Growth (BIG10) Conference taking place in New York City on September 10, 2026.

Authentic Interactions (AI, Inc), creator of Lookalike, StoryFile, and Authentex, today announced a partnership with Soniox, a leading provider of real-time speech recognition technology. Under the partnership, Soniox will power the speech recognition layer for Lookalike and StoryFile, enabling more accurate, natural, and multilingual conversations with digital humans.

CHICAGO, August 24, 2026--Tempus AI, Inc. (NASDAQ: TEM) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Tempus ECG-PH (pulmonary hypertension), an AI-enabled software device that analyzes standard 12-lead electrocardiograms (ECGs) for signs associated with pulmonary hypertension. Tempus ECG-PH is the third FDA-cleared device in Tempus’ growing cardiovascular portfolio, expanding the company’s suite of next-generation AI products aimed at iden

SANTA CLARA, Calif., August 18, 2026--Velaura AI, Inc., an AI compute infrastructure company developing ultra-low-power silicon and software technologies, today announced that it has raised $110 million in Series A financing, bringing its total valuation to more than $1 billion. The round reflects investor conviction in a proven technology foundation, multiple hyperscaler engagements, an experienced leadership team, and a vision for AI compute spanning data centers and Physical AI.

SAN FRANCISCO & GUANGZHOU, China, August 14, 2026--Pony AI Inc. ("Pony.ai") (NASDAQ: PONY; HKEX: 2026), a global leader in the large-scale commercialization of autonomous driving technology, and Uber Technologies, Inc. ("Uber") (NYSE: UBER) today announced an expansion of their strategic partnership, with plans to collaborate on the deployment of more than 2,000 Pony.ai Robotaxis across Europe.

CHICAGO, July 20, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that it has entered into a definitive agreement to acquire Personalis, Inc. (NASDAQ: PSNL). The acquisition will expand Tempus' capabilities in minimal residual disease (MRD) and enhance its ability to support patients from diagnosis and treatment selection, to recurrence and monitoring.

CHICAGO, June 25, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a research collaboration with Angiosarcoma Awareness, Inc. to accelerate data-driven research in angiosarcoma, one of the rarest and most aggressive cancers. Angiosarcoma is a rare malignant tumor that starts in endothelial cells, which form the inner lining of blood vessels. It is known for its aggressive behavior, rapid progressi

SANTA CLARA, Calif., June 22, 2026--Upscale AI, Inc., a pure-play AI networking infrastructure company, today announced it has raised $190 million in Series A-1 financing. This latest investment brings the company’s total funding to $500 million, and its current valuation to $2 billion, reflecting strong investor conviction in the AI networking market and Upscale AI’s unique innovation in driving open-standards solutions for it.

CHICAGO, June 05, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference.

CHICAGO, May 31, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus’ multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the pace required for drug development.

Company reports approximately $30 Million in cash, sufficient to fund operations through demonstration milestoneNEW YORK, NY, May 18, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) (the “Company” or “Fabri.AI”), an AI infrastructure company developing a suite of fabless semiconductor technologies for next-generation AI factories, today announced that it expects to demonstrate its flagship Neural I/o™ MicroLED-based optical interconnect platform by the end of 2026. Neural I/o is being de